Cinnamic aldehydes affect hydrolytic enzyme secretion and morphogenesis in oral Candida isolates.
Effect of cinnamaldehyde (CD), 4-hydroxy-3-methoxy cinnamaldehyde (HMCD) and 3,5-dimethoxy-4-hydroxy cinnamaldehyde (HDMCD) on growth and virulence factors of standard (Candida albicans 90028) and 26 oral isolates of C. albicans has been investigated. Growth was significantly inhibited by all three compounds in both solid and liquid medium, no systematic difference was observed between various isolates. MIC₉₀ ranged from 125 to 450 μg/ml for CD, 100-250 μg/ml for HMCD and 62.5-125 μg/ml for HDMCD. All oral isolates were found to be proteinase and phospholipase secretors, both proteinase and phospholipase secretion was significantly inhibited by all the three tested molecules. No systematic difference in secretion or its inhibition was observed between standard and oral isolates as also between various isolates. Average drop in proteinase and phospholipase secretion caused by ½ MIC of CD was 33% and 28%, HMCD; 46% and 44%, HDMCD; 59% and 54%. The standard strain and all the 26 oral isolates displayed morphogenesis under triggering experimental conditions; no difference was seen between standard and various isolates. In the absence of test compounds hyphae development at 300 min was 83% for standard strain whereas average hyphae development for oral isolates was 85%. Average hyphal transition was suppressed by all tested compounds. At ½ MIC concentration at 300 min average hyphal transition of standard and oral isolates was CD; 49% and 57%, HMCD; 45% and 38%, HDMCD; 5% and 5%. Average haemolytic activity of the three tested compounds varied from 10 to 15% at their highest MIC compared to 20% shown by fluconazole at typical MIC of 30 μg/ml.
Department of Biosciences, Jamia Millia Islamia, New Delhi 110025, India.
Sheikh
S
Shreaz
Rimple
R
Bhatia
Neelofar
N
Khan
Indresh Kumar
IK
Maurya
Sheikh Imran
SI
Ahmad
Sumathi
S
Muralidhar
Nikhat
N
Manzoor
Luqman A
LA
Khan
D000171:Acrolein / Q000031:analogs & derivatives* / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology*; D002176:Candida albicans / Q000187:drug effects* / Q000201:enzymology / Q000254:growth & development* / Q000302:isolation & purification; D002180:Candidiasis, Oral / Q000382:microbiology*; D005656:Fungal Proteins / Q000378:metabolism*; D006801:Humans; D025301:Hyphae / Q000187:drug effects / Q000201:enzymology / Q000235:genetics / Q000254:growth & development; D008826:Microbial Sensitivity Tests; D010447:Peptide Hydrolases / Q000378:metabolism; D010740:Phospholipases / Q000378:metabolism; D021381:Protein Transport
D000935:Antifungal Agents; D005656:Fungal Proteins; D000171:Acrolein; D010740:Phospholipases; D010447:Peptide Hydrolases; C012843:cinnamaldehyde